1. Opportunistic screening for hypertension: what does it say about the true epidemiology?
- Author
-
Rigas Kalaitzidis, George S. Stergiou, Yannis Alamanos, Pantelis Sarafidis, Michael Doumas, Angeliki Ntineri, Maria E. Marketou, Paraskevi V. Voulgari, Grigoris Chlouverakis, Christos Hadjichristodoulou, Eugenia Gkaliagkousi, Dimitrios Papadopoulos, Pantelis Zebekakis, Michail Chatzopoulos, Natasa Kalpourtzi, G. Trypsianis, John A Papadakis, Xenophon Krokidis, Magda Gavana, Ariadni Menti, Efstathios Manios, Argiro Karakosta, Manolis S. Kallistratos, Giota Touloumi, Apostolos Vantarakis, and Vasiliki Katsi
- Subjects
Adult ,Male ,medicine.medical_specialty ,Population ,Blood Pressure ,030204 cardiovascular system & hematology ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Epidemiology ,Internal Medicine ,medicine ,Humans ,030212 general & internal medicine ,education ,Opportunistic screening ,Antihypertensive Agents ,education.field_of_study ,business.industry ,Reproducibility of Results ,Rate control ,Mean age ,Stratified sampling ,Cross-Sectional Studies ,Blood pressure ,Hypertension ,Female ,business ,Body mass index - Abstract
This study aimed to assess the reliability of opportunistic screening programs in estimating the prevalence, treatment, and control rate of hypertension in the general population. Two recent epidemiological surveys obtained data on hypertension in the adult general population in Greece. The EMENO (2013–2016) applied a multi-stage stratified random sampling method to collect nationwide data. The MMM (2019) collected data through opportunistic (voluntary) screening in five large cities. Hypertension was defined as blood pressure (BP) ≥ 140/90 mmHg (single occasion; average of 2nd–3rd measurement; electronic devices) and/or use of antihypertensive drugs. Data from a total of 10,426 adults were analyzed (EMENO 4,699; MMM 5,727). Mean age (SD) was 49.2 (18.6)/52.7 (16.6) years (EMENO/MMM, p
- Published
- 2021